Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Roche Holding AG (OTCQX International Premier:RHHVF)

Delayed Data
As of Dec 08
 -5.72 / -2.33%
Today’s Change
Today|||52-Week Range
Puma (PBYI) Stock Up More than 200% This Year: Here's Why
Dec 08 / Zacks.com - Paid Partner Content
Janssen, AbbVie's Imbruvica Achieves PFS in Innovate Study
Dec 06 / GuruFocus News - Paid Partner Content
Pharma Stock Roundup: FDA Nod for NVO's Ozempic, Second Indication for Lilly's Taltz
Dec 08 / Zacks.com - Paid Partner Content
AbbVie/J&J's Imbruvica Succeeds in Combo Study with Rituxan
Dec 06 / Zacks.com - Paid Partner Content
Roche Reports Tecentriq/Avastin Lung Cancer Study Data
Dec 07 / Zacks.com - Paid Partner Content
Building a Circle of Competency
Dec 05 / GuruFocus News - Paid Partner Content
Clovis' sNDA for Rubraca Gets Priority Review in the U.S.
Dec 06 / Zacks.com - Paid Partner Content
Mylan Up on FDA Approval & Amazon's Rumored Pharmacy Interest
Dec 04 / Zacks.com - Paid Partner Content
Roche's Avastin Gets Full FDA Approval for Brain Cancer
Dec 06 / Zacks.com - Paid Partner Content
Cancer Space Update: Pfizer's Bavencio Fails in Phase III
Dec 01 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close246.00
Today’s open240.28
Day’s range240.28 - 240.28
Average volume (3 months)2,766
Market cap$168.8B
Dividend yield3.41%
Data as of 3:52pm ET, 12/08/2017

Growth & Valuation

Earnings growth (last year)+5.53%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+2.67%
P/E ratio18.3


No competitors data available.


Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$51.3B
Annual profit (last year)$9.7B
Net profit margin18.93%


Health Technology
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Severin Schwan
Chief Financial &
Information Technology Officer
Alan Hippe
Corporate headquarters
Basel, Basel-stadt (basle Town)